A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus
Clinical trial NCT05816057 · COMPLETED
Trial details
- NCT number
- NCT05816057
- Sponsor
- Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-25
- Primary completion
- 2023-07-25
- Enrollment
- 476
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.